| bibliographicCitation |
Tanaka M, Yamakage H, Masuda S, Inoue T, Ohue-Kitano R, Araki R, Matoba Y, Saito M, Nagaoka T, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Nishimura M, Odori S, Wada H, Kotani K, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N. Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes. Diabetes Metab. 2019 Jan;45(1):86–9. doi: 10.1016/j.diabet.2017.06.006. PMID: 28774784. |